Heart Supplements: What Magnesium, Potassium, CoQ10, Fish Oil, and Vitamin D Actually Do

Last week a patient set a Trader Joe's tote bag on my desk and started pulling out bottles. Magnesium glycinate from Costco. Potassium pills from a vitamin shop. Two different CoQ10 brands because she wasn't sure which one was better. Fish oil from Whole Foods. A vitamin D her chiropractor recommended. She is 68, on a water pill, on a statin, and on a blood thinner for atrial fibrillation. She wanted to know which were helping her heart and which were a waste of money. She had no idea that two of them could interact with her prescriptions in ways that could land her in the emergency room.

This happens in my clinic every week. Supplements are a $50 billion industry, the bottles look medical, and most of my patients arrive taking three or four without ever telling their doctor. Some have real evidence. Some have modest evidence. A few are dangerous stacked on cardiac medications. I want to walk you through the ones I get asked about most.

Magnesium

Magnesium is the supplement I am most willing to recommend. It is a mineral your body uses for nerve and muscle function, blood pressure regulation, and the steady electrical activity of the heart. The recommended daily intake is around 320 mg for women and 420 mg for men. Roughly half of American adults fall below those numbers, mostly because we eat fewer leafy greens, nuts, beans, and whole grains and more processed food, which has had most of the magnesium stripped out.

Deficient versus supplemented

This is the most important thing to understand. Most of the heart benefits attributed to magnesium come from correcting a low level, not from pushing a normal level higher. If your blood magnesium is normal and your diet is decent, taking 400 mg of magnesium glycinate at bedtime is unlikely to do much for your heart. If you are running low, which a lot of patients quietly are, replacing what you are missing can settle palpitations, ease leg cramps, lower blood pressure a few points, and improve sleep. The size of the benefit tracks the size of the deficiency.

Magnesium and arrhythmias

Patients ask me almost every week whether magnesium will prevent palpitations or AFib. The data are mixed and the effect is modest. Intravenous magnesium reduces AFib after open-heart surgery. Very low magnesium levels make the upper chambers electrically jumpy and can trigger arrhythmias. We do not have strong evidence that an oral magnesium supplement in someone with normal levels prevents AFib or stops palpitations on a routine basis.

In clinic I will often suggest a trial of magnesium for a patient with frequent benign palpitations, especially if they are on a water pill, drink a lot of coffee, or eat a low-magnesium diet. Many feel better. Some of that is real, some is placebo. Magnesium is not a substitute for a proper rhythm workup. If you are having episodes of a racing or pounding heart, you need an evaluation.

Magnesium and blood pressure

Across roughly 30 randomized trials, 300 to 500 mg per day lowers systolic blood pressure by about 2 mmHg and diastolic by about 1.8 mmHg. The effect is larger in people who started off deficient, negligible in people with normal levels. A typical blood pressure medication lowers the top number by 10 to 15 mmHg. Magnesium is an add-on, not a replacement.

Magnesium with PPIs and water pills

This is where I most commonly find patients who genuinely need magnesium. Long-term PPIs (omeprazole, esomeprazole, pantoprazole, lansoprazole) can drop magnesium after a year or more of use. The FDA warned on these years ago. If you have been on a PPI long-term and have leg cramps, fatigue, or palpitations, ask for a magnesium level.

Loop diuretics like furosemide and torsemide, which we use in heart failure, waste magnesium in the urine. Thiazides like hydrochlorothiazide and chlorthalidone do the same. Patients on these drugs often run low on both magnesium and potassium without realizing it. If your cardiologist has you on a water pill and has not checked these levels in a while, ask about it.

Forms of magnesium

Magnesium oxide is cheap, poorly absorbed, and acts mostly as a laxative. Avoid it unless that is what you wanted. Magnesium glycinate is my usual recommendation: well absorbed, gentle on the gut, and the glycine has a mild calming effect that helps with sleep. Magnesium citrate is also reasonably absorbed and can loosen the bowels. Magnesium L-threonate is expensive and not better for the heart.

Dose and the kidney caveat

If we decide a magnesium trial is reasonable, I usually suggest 200 to 400 mg of elemental magnesium glycinate at bedtime. The label sometimes lists "magnesium glycinate 1,000 mg," which is the weight of the whole compound, so look for "elemental magnesium" on the back of the bottle.

Magnesium is cleared by your kidneys. With impaired kidney function it can build up and cause rhythm problems. Anyone with chronic kidney disease, an estimated GFR below 45 or so, should talk to their doctor before starting magnesium and avoid the high doses at health food stores. Same goes for dialysis patients.

Potassium

Potassium is one of the most important minerals for blood pressure and rhythm, and one of the most poorly understood. Almost every patient is getting too little from their diet. Almost none should be taking a potassium pill. Both are true.

The 4,700 mg target most people miss

The daily intake target is around 4,700 mg. The average American eats 2,500 to 3,000 mg per day. Higher dietary potassium is linked to lower blood pressure, fewer strokes, and lower cardiovascular mortality. Our diet is too high in sodium and too low in potassium, and that ratio is part of why hypertension is so common here.

Food first, almost always

The way to fix a potassium gap is through food, not pills. Bananas are famous, and they are fine, and they are not actually the highest source. A baked potato with the skin has about twice the potassium of a banana. Sweet potatoes, white beans, lentils, salmon, avocado, spinach, Swiss chard, and yogurt are all rich sources. Fresh, unprocessed plant foods carry potassium with them. Processed foods strip it out.

Why we don't usually use potassium pills

If low potassium is bad, surely a potassium pill must be good? Potassium has a narrow safe window. Too low is dangerous. Too high can cause life-threatening rhythm problems and cardiac arrest. Over-the-counter potassium supplements are capped at 99 mg per pill for that reason. The kidneys regulate potassium tightly, and any condition or medication that interferes with that regulation can flip a normal level into a dangerous one quickly. Routine potassium pills are not something I recommend.

Salt substitutes and the rural China trial

Here is the most interesting recent development. A large trial in rural China randomized about 21,000 adults at high cardiovascular risk to either regular salt or a salt substitute that was 75 percent sodium chloride and 25 percent potassium chloride. The substitute group used the new salt at home for cooking and seasoning. After about five years, the substitute group had roughly 14 percent fewer strokes, 13 percent fewer cardiovascular deaths, and 12 percent fewer deaths from any cause compared with the regular salt group. The trial was published in the New England Journal of Medicine in 2021. The size of the effect is striking for such a simple intervention.

Should you switch to a potassium-based salt substitute? For some patients, yes. For others, absolutely not. The asterisks matter. If you have normal kidney function and are not on certain blood pressure medications, a salt substitute is reasonable and probably helpful. If you have any of the following, do not use one without talking to your doctor first: chronic kidney disease, an ACE inhibitor like lisinopril or enalapril, an ARB like losartan or valsartan, spironolactone, eplerenone, or a potassium-sparing diuretic. These conditions and medications all raise potassium on their own, and adding more from a salt substitute can drive your level into a dangerous range. Patients in the China trial were screened for some of these conditions. The benefit was real. So are the risks for the wrong patient.

CoQ10

CoQ10, short for coenzyme Q10, is the most asked-about cardiac supplement after magnesium. Patients bring in bottles of ubiquinone or ubiquinol and ask whether they should keep taking it, whether the more expensive form is worth the money, and whether it can fix the muscle aches they get from their statin. The honest version follows.

What CoQ10 does

CoQ10 is a fat-soluble compound your body makes naturally and uses in the energy factories inside your cells. The heart, with its high energy demand, carries a lot of it. Production declines with age, and levels in the heart muscle are lower in heart failure patients than in healthy controls.

The statin theory and what trials show

Statins lower cholesterol by blocking the chemistry that makes statins work. The same chemistry, a step earlier, also produces CoQ10. So statins measurably lower blood CoQ10 levels. The intuitive jump is that statin muscle aches must come from CoQ10 depletion, and that supplementing CoQ10 should fix them. This idea has been around for two decades and has filled a lot of supplement aisles.

The data are less rosy than the marketing. Several meta-analyses have pooled small randomized trials of CoQ10 in statin muscle pain. Different reviews reach different conclusions. The most recent pooled analyses do not reliably show that CoQ10 reduces statin-related muscle pain. Trials are small and short, and the placebo effect in muscle pain is large.

My honest read. CoQ10 is safe, and some patients tell me it helps. I do not stop them from trying it. The trial evidence does not support routine use, and there are usually better first steps: confirming the symptoms really track with the statin, lowering the dose, switching to a different statin, or taking it every other day.

CoQ10 in heart failure

This is where the evidence is more interesting. A randomized trial of about 420 patients with moderate to severe heart failure, run mostly in Europe, gave half of them 100 mg of CoQ10 three times daily on top of standard heart failure medications, and the other half a placebo. After two years, cardiovascular death dropped from 16 percent to 9 percent, and total mortality dropped from 18 percent to 10 percent. For a supplement, those are impressive results.

The caveats are real. The trial predated the modern heart failure regimen, which now uses four classes of medication that save lives. Whether CoQ10 adds anything on top of that is not proven. The trial has not been replicated at scale. The 2022 American heart failure guidelines do not endorse CoQ10. A 2023 AHA statement called it of uncertain value.

In my own practice, I will sometimes discuss CoQ10 with a patient who has heart failure with reduced pumping function, framed honestly as a supplement with one good trial behind it and not as a replacement for the medications that we know save lives. The dose used in the trial was 300 mg per day total, split into three doses. Lower doses in store-shelf bottles, like 50 or 100 mg once daily, are less likely to do much.

Dose, form, and cost

Heart failure trial data used 100 to 300 mg daily, split into two or three doses, in the ubiquinone form. Ubiquinol is marketed as more bioavailable, and the price difference is steep. For most patients, ubiquinone at the right dose works fine. A reasonable brand at a useful dose runs $30 to $60 per month. If that money is competing with a gym membership, fresh produce, or your prescription copays, the medications and the produce will move your numbers more than the CoQ10 will.

Fish Oil

Fish oil is a humbling story for cardiology. For two decades, fish oil capsules were sold as routine heart-protective supplements. The science behind that recommendation has weakened considerably.

The fall from grace

Three large randomized trials in the past decade tested 1 gram per day omega-3 in adults at moderate cardiac risk. The largest, with about 25,000 American adults, ran for five years and did not significantly reduce overall cardiac events. There was a smaller signal for fewer heart attacks in people who ate little fish at baseline. Two other trials, one in diabetes and one in elevated cardiac risk, also did not show clear benefit at standard doses.

The routine fish oil capsule from Costco is unlikely to do much for the average person's cardiac risk. If you do not eat much fish and want to hedge, fine. If you eat fish twice a week, skip the capsule.

Prescription icosapent ethyl is different

There is one important exception. A prescription form of purified omega-3, called icosapent ethyl, was tested at a much higher dose, 4 grams per day, in adults with high triglycerides who were already on a statin. That trial showed about a 25 percent reduction in major cardiovascular events. This is not the same product as grocery store fish oil. The dose is four times higher, the form is a single isolated EPA fatty acid, and the patients enrolled had specific cardiac risk profiles. If your doctor has prescribed icosapent ethyl, the data behind it are real. A bottle of mixed omega-3s from the grocery store is a different intervention with a different evidence base.

The atrial fibrillation signal at high doses

Across several recent high-dose omega-3 trials, new atrial fibrillation was modestly more common on omega-3 than placebo. The signal is consistent enough that I bring it up with my AFib patients before recommending fish oil. If you already have AFib, high-dose omega-3 is probably not the right tool. A standard 1 gram dose is usually fine. With a history of frequent AFib episodes, I suggest skipping fish oil and getting omega-3s from food.

Vitamin D

Vitamin D might be the most over-supplemented vitamin in America. The largest randomized trial of vitamin D for cardiovascular prevention, with about 25,000 adults followed for a median of five years, gave half 2,000 IU daily and half a placebo. There was no reduction in heart attacks, strokes, or cardiovascular deaths. Subsequent analyses have not changed that conclusion. Vitamin D does not appear to protect the heart in adults with normal levels.

If your blood level is genuinely low, supplementation matters for bone health, and your doctor will guide the dose. Most adults with a level above 20 ng/mL do not need to supplement for cardiac reasons. Do not take vitamin D for your heart.

The Big Picture

Supplements rarely outperform diet

In nearly every category here, the food version beats the pill. Leafy greens, beans, and whole grains beat a magnesium pill. Potatoes, beans, and salmon beat a potassium pill. Fish twice a week beats a fish oil capsule. The supplement aisle promises shortcuts the trial data do not deliver.

The industry is poorly regulated

Supplements in the United States are regulated as food, not drugs. The FDA does not check the contents before the bottle hits the shelf. Independent testing has repeatedly found products containing less of the active ingredient than the label claims, and sometimes things the label does not mention. Look for USP or NSF certification on the label. Those organizations test for purity and potency.

Tell your cardiologist what you take

Many patients do not mention supplements at their cardiology visit because they assume supplements do not count. They count. They interact with medications, they affect bleeding, blood pressure, kidney function, and rhythm. Bring the bottles or a written list to your next visit.

The dangerous combinations to know

Red yeast rice and statins. Red yeast rice contains a natural form of lovastatin. Stacking it on a prescription statin doubles the dose without the prescription bottle saying so, and can cause muscle and liver problems.

Grapefruit juice and certain cardiac medications. Grapefruit interferes with the way the liver clears several blood pressure pills, statins, and the calcium channel blocker amlodipine. The medication level can rise unexpectedly. Most cardiac patients should keep grapefruit out of their daily routine unless their doctor has cleared it.

Garlic supplements and warfarin. High-dose garlic capsules can thin the blood, and combined with warfarin can push the level into a dangerous range. Eating garlic in food is fine. The concentrated supplements are different.

Fish oil and warfarin or other blood thinners. High-dose fish oil can increase bleeding risk on top of an anticoagulant. Standard doses, 1 gram per day or so, are usually fine, and you should still tell your cardiologist what you take.

St. John's wort and many cardiac medications. This herbal product is a strong inducer of the liver enzymes that clear several heart drugs and blood thinners. It can drop the level of your medication and make it less effective. Generally avoid it if you are on cardiac drugs.

The Closing Ask

Bring your supplement bag to your next visit. Dump it on the table the way my patient did last week. Five minutes of going through the bottles can save you from a bad combination, save you money on supplements that are not doing anything, and sometimes flag a real deficiency we should treat.

If you take one thing from this, take this. Magnesium glycinate at 200 to 400 mg of elemental magnesium at bedtime is reasonable without significant kidney disease. Potassium should come from food, with salt substitutes an option for people without the contraindications. CoQ10 is reasonable in heart failure with reduced pumping function and underwhelming for everything else. Standard-dose fish oil is unlikely to do much, and prescription icosapent ethyl is a different story. Vitamin D is not a heart supplement. Every supplement on your shelf belongs on your medication list.

References

1. Rosanoff, Andrea, Connie M. Weaver, and Robert K. Rude. "Suboptimal Magnesium Status in the United States: Are the Health Consequences Underestimated?" Nutrition Reviews 70, no. 3 (2012): 153-164.

2. Zhang, Xi, Yufeng Li, Liana C. Del Gobbo, Andrea Rosanoff, Jia Wang, Wen Zhang, and Yiqing Song. "Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials." Hypertension 68, no. 2 (2016): 324-333.

3. Salaminia, Saber, Fatemeh Sayehmiri, Pouria Angha, Kourosh Sayehmiri, and Mohammadreza Motedayen. "Evaluating the Effect of Magnesium Supplementation on Cardiac Arrhythmias After Acute Cardiac Surgery: A Systematic Review and Meta-Analysis." BMC Cardiovascular Disorders 18, no. 1 (2018): 129.

4. Neal, Bruce, Yangfeng Wu, Xiangxian Feng, Ruijuan Zhang, Yuhong Zhang, Jingpu Shi, Jianxin Zhang, et al. "Effect of Salt Substitution on Cardiovascular Events and Death." New England Journal of Medicine 385, no. 12 (2021): 1067-1077.

5. Aburto, Nancy J., Sara Hanson, Hialy Gutierrez, Lee Hooper, Paul Elliott, and Francesco P. Cappuccio. "Effect of Increased Potassium Intake on Cardiovascular Risk Factors and Disease: Systematic Review and Meta-Analyses." BMJ 346 (2013): f1378.

6. Mortensen, Svend A., Franklin Rosenfeldt, Adarsh Kumar, Peter Dolliner, Krzysztof J. Filipiak, Daniel Pella, Urban Alehagen, Gunter Steurer, and Gian P. Littarru. "The Effect of Coenzyme Q10 on Morbidity and Mortality in Chronic Heart Failure: Results From Q-SYMBIO: A Randomized Double-Blind Trial." JACC: Heart Failure 2, no. 6 (2014): 641-649.

7. Banach, Maciej, Corina Serban, Sorin Ursoniu, Jacek Rysz, Paul Muntner, Peter P. Toth, Steven R. Jones, et al. "Statin Therapy and Plasma Coenzyme Q10 Concentrations: A Systematic Review and Meta-Analysis of Placebo-Controlled Trials." Pharmacological Research 99 (2015): 329-336.

8. Qu, Hua, Mengmeng Guo, Hua Chai, Wen-ting Wang, Zhuye Gao, and Da-zhuo Shi. "Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials." Journal of the American Heart Association 7, no. 19 (2018): e009835.

9. Manson, JoAnn E., Nancy R. Cook, I-Min Lee, William Christen, Shari S. Bassuk, Samia Mora, Heike Gibson, et al. "Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer." New England Journal of Medicine 380, no. 1 (2019): 23-32.

10. Manson, JoAnn E., Nancy R. Cook, I-Min Lee, William Christen, Shari S. Bassuk, Samia Mora, Heike Gibson, et al. "Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease." New England Journal of Medicine 380, no. 1 (2019): 33-44.

11. Bhatt, Deepak L., P. Gabriel Steg, Michael Miller, Eliot A. Brinton, Terry A. Jacobson, Steven B. Ketchum, Ralph T. Doyle Jr., et al. "Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia." New England Journal of Medicine 380, no. 1 (2019): 11-22.

12. Nicholls, Stephen J., A. Michael Lincoff, Michelle Garcia, Dianna Bash, Christie M. Ballantyne, Philip J. Barter, Michael H. Davidson, et al. "Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at high Cardiovascular Risk: The STRENGTH Randomized Clinical Trial." JAMA 324, no. 22 (2020): 2268-2280.

Published on damianrasch.com. The above information was composed by Dr. Damian Rasch, drawing on individual insight and bolstered by digital research and writing assistance by an AI chatbot. The information is for educational purposes only and does not constitute medical advice.

Hello, World!